Australia markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.45+0.46 (+2.42%)
At close: 1:00PM EST
19.85 +0.40 (+2.06%)
After hours: 04:54PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 51.36B
Enterprise value 31.20B
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)8.66
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-32.33

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3264.92%
S&P500 52-week change 326.87%
52-week high 331.50
52-week low 34.51
50-day moving average 319.07
200-day moving average 317.14

Share statistics

Avg vol (3-month) 3795.19k
Avg vol (10-day) 3808.11k
Shares outstanding 575.71M
Implied shares outstanding 6N/A
Float 873.66M
% held by insiders 13.20%
% held by institutions 127.83%
Shares short (14 Nov 2021) 44.41M
Short ratio (14 Nov 2021) 46.26
Short % of float (14 Nov 2021) 46.02%
Short % of shares outstanding (14 Nov 2021) 45.83%
Shares short (prior month 14 Oct 2021) 45.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4
Last split date 306 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2021
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-23.87%
Return on equity (ttm)-42.58%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-37.91M
Diluted EPS (ttm)-0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)152.11M
Total cash per share (mrq)2
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)14.97
Book value per share (mrq)1.99

Cash flow statement

Operating cash flow (ttm)-30.38M
Levered free cash flow (ttm)-15.9M